NCT05753800

Brief Summary

The goal of this Clinical Trial is to verify the effectiveness of the use of the Intorus device in the motor intervention in patients with cerebral palsy and related syndromes. The main question it aims to answer is: Does the use of the Intorus tool manage to improve the mobility of upper limbs (MMSS) in patients with infantile cerebral palsy to increase their performance in activities of daily living? A total of approximately 50 users will participate in the study. Participants will be divided into two groups randomly. The control group will receive an intervention treatment at the motor level in the traditional way, following the protocols established in the center, and the intervention group will receive an intervention treatment at the motor level with the INTORUS device. Randomization will be carried out using the Oxford Minimization and Randomization software.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

January 30, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 3, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2023

Completed
Last Updated

December 1, 2023

Status Verified

November 1, 2023

Enrollment Period

6 months

First QC Date

January 30, 2023

Last Update Submit

November 30, 2023

Conditions

Keywords

cerebral palsymotor activitymotor disorders

Outcome Measures

Primary Outcomes (1)

  • IMPROVEMENT OF UPPER LIMB MOBILITY AS MEASURED BY GONIOMETER

    Measuring joint amplitude of upper limb joints with goniometer

    Before starting treatment. After 20 weeks of treatment and at the end of treatment (40 weeks).

Secondary Outcomes (1)

  • Functional Gesture of Activities of Daily Living

    Before starting treatment. After 20 weeks of treatment and at the end of treatment (40 weeks).

Other Outcomes (2)

  • Professional satisfaction questionnaire

    Through study completion, an average of 6 months

  • Participants satisfaction questionnaire

    Through study completion, an average of 6 months

Study Arms (2)

Experimental group

EXPERIMENTAL

This group receives motor intervention sessions with the Intorus device

Device: INTORUS

Control group

NO INTERVENTION

This group receives no motor intervention sessions with the Intorus device

Interventions

INTORUSDEVICE

Motor intervention protocol with Intorus consisting of a series of exercises of progressive difficulty

Experimental group

Eligibility Criteria

Age4 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Users with infantile cerebral palsy and/or related syndromes.
  • Ages between 4 and 18 years.
  • Motor disability.
  • Affectation in the mobility of upper limbs.
  • Informed consent signed by parents/guardians.

You may not qualify if:

  • Patients with another type of pathology not related to cerebral palsy.
  • Under 4 years and over 18 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Blanca González Sánchez

Cáceres, Caceres, 10001, Spain

Location

MeSH Terms

Conditions

Cerebral PalsyMotor DisordersMotor Activity

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMental DisordersBehavior

Study Officials

  • Blanca González Sánchez, Doctor

    Universidad de Extremadura

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

January 30, 2023

First Posted

March 3, 2023

Study Start

January 1, 2023

Primary Completion

June 30, 2023

Study Completion

August 31, 2023

Last Updated

December 1, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations